VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 22 filers reported holding VASCULAR BIOGENICS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,910 | -5.9% | 16,000 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $4,157 | +55.1% | 16,000 | 0.0% | 0.01% | +50.0% |
Q1 2023 | $2,681 | +39.6% | 16,000 | 0.0% | 0.00% | +33.3% |
Q4 2022 | $1,920 | -4.0% | 16,000 | 0.0% | 0.00% | +50.0% |
Q3 2022 | $2,000 | -92.6% | 16,000 | 0.0% | 0.00% | -92.0% |
Q1 2022 | $27,000 | -15.6% | 16,000 | 0.0% | 0.02% | -13.8% |
Q4 2021 | $32,000 | – | 16,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |